Article
The tetramerization domain-independent Ras activation by BCR-ABL oncoprotein in hematopoietic cells.
International journal of oncology - 1 Jun 1998
Tauchi T, Okabe S, Miyazawa K, Ohyashiki K
Abstract excerpt
BCR-ABL is a chimeric oncoprotein that exhibits deregulated tyrosine kinase activity and is implicated in the pathogenesis of Philadelphia chromosome-positive human leukemias. We have previously shown that BCR-ABL activates Ras signaling pathways required for transformation. To elucidate the mechanisms whereby BCR-ABL induced transformation in hematopoietic cells, we examined the biological effects of expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
